Irma Bagdoniene: Plaque Stability and the Importance of LDL Lowering
Irma Bagdoniene, Cardiologist Specializing in Prevention and Lipidology, shared Atherosclerosis’ post on LinkedIn, adding:
“Excellent summary.
We often focus on the degree of stenosis, but plaque composition and stability are equally important.
Another compelling reason to optimize LDL-C lowering as early as possible! ”
Atherosclerosis shared a post on LinkedIn about a recent article by Pruthvi C. Revaiah et al., adding:
“What if the coronary plaques that matter most are not always the ones causing the greatest obstruction?
Non-obstructive plaques can still be lipid-rich, biologically active, and clinically relevant.
In the YELLOW III sub-study, intensive lipid-lowering therapy with evolocumab plus statins reduced lipid-rich plaque components and was accompanied by a modest improvement in coronary physiology.
AI-based OCT helped connect changes in plaque composition with functional remodeling.
The findings raise an intriguing question: could treating plaque biology be just as important as treating stenosis?”
Title: Serial OCT-based coronary physiology and plaque composition in vessels with nonobstructive coronary lesions following intensive lipid-lowering therapy: YELLOW III sub-study
Authors: Pruthvi C. Revaiah, Yuliya Vengrenyuk, Vemuri Krishna Santosh, Monika Karki, Keisuke Yasumura, Khushal Choudhary, Ishani Bansal, Joseph M. Sweeny, Sahil Khera, Vishal Kapur, Amit Hooda, Prakash Krishnan, Pedro R. Moreno, Roxana Mehran, Jagat Narula, Samin K. Sharma, Annapoorna S. Kini

Other posts featuring Irma Bagdoniene on Hemostasis Today.
-
Aug 9, 2026, 11:22Saqib Ullah: Why Do Red Blood Cells Autoagglutinate
-
Aug 9, 2026, 11:06Oumayma Mnafe: ThroLy and IMPEDE VTE Scores in Hematologic Malignancies
-
Aug 9, 2026, 10:06Care Shouldn’t Depend on Where You Live – National Bleeding Disorders Foundation
-
Aug 9, 2026, 09:49Rana Al-Dhalaan: New Study Examines Viral Infections in Blood Donors
-
Aug 9, 2026, 09:29Michael Wilkinson: How Lp(a) Shapes Coronary Plaque and Cardiovascular Risk
-
Aug 9, 2026, 09:16Preparing for Gene Therapy Starts with Understanding Immunity – WFH
-
Aug 9, 2026, 08:46Christina Pohlman: Uncovering the Autoantibodies Behind APS
-
Aug 9, 2026, 08:39Alejandro González Veliz: The Future of Cardiogenic Shock Lies in Precision Medicine
-
Aug 9, 2026, 08:29Heba Youssef: Off-Label Doesn’t Mean Off-Guidelines